Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA030924-05
Application #
4691325
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Hackman, R C; Wolford, J L; Gleaves, C A et al. (1994) Recognition and rapid diagnosis of upper gastrointestinal cytomegalovirus infection in marrow transplant recipients. A comparison of seven virologic methods. Transplantation 57:231-7
Buchsel, P C; Kelleher, J (1989) Bone marrow transplantation. Nurs Clin North Am 24:907-38
Gelinas, R E; Bender, M A; Miller, A D et al. (1989) Long-term expression of the human beta-globin gene after retroviral transfer into pluripotent hematopoietic stem cells of the mouse. Adv Exp Med Biol 271:135-48
Gelinas, R E; Bender, M A; Miller, A D (1989) Regulated expression of the human beta-globin gene after retroviral transfer into murine and human hematopoietic cells. Prog Clin Biol Res 316B:235-49
Bender, M A; Gelinas, R E; Miller, A D (1989) A majority of mice show long-term expression of a human beta-globin gene after retrovirus transfer into hematopoietic stem cells. Mol Cell Biol 9:1426-34
Sale, G E; Buckner, C D (1988) Pathology of bone marrow in transplant recipients. Hematol Oncol Clin North Am 2:735-56
Kolbinson, D A; Schubert, M M; Flournoy, N et al. (1988) Early oral changes following bone marrow transplantation. Oral Surg Oral Med Oral Pathol 66:130-8
Lenssen, P; Cheney, C L; Aker, S N et al. (1987) Intravenous branched chain amino acid trial in marrow transplant recipients. JPEN J Parenter Enteral Nutr 11:112-8
Klingemann, H G; Maunder, R J; Storb, R (1987) Reduced monocyte-associated fibronectin in patients after allogeneic marrow transplantation. Transplantation 43:454-7
Shepp, D H; Dandliker, P S; Flournoy, N et al. (1987) Sequential intravenous and twice-daily oral acyclovir for extended prophylaxis of herpes simplex virus infection in marrow transplant patients. Transplantation 43:654-8

Showing the most recent 10 out of 117 publications